849
Views
25
CrossRef citations to date
0
Altmetric
Review

Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?

, MD (Assistant Professor of Psychiatry) (Assistant Director) (Assistant Professor of Psychiatry) (Assistant Director) , , MD (Child and Adolescent Psychiatry Fellow) , , MD (Child and Adolescent Psychiatry Fellow) & , MD (Assistant Professor of Pediatrics)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Emma van Andel, Denise Bijlenga, Suzan W. N. Vogel, Aartjan T. F. Beekman & J. J. Sandra Kooij. (2023) Cardiovascular risk in adults with Delayed Sleep Phase Syndrome (DSPS) and Attention-Deficit/Hyperactivity Disorder (ADHD). Chronobiology International 40:12, pages 1566-1573.
Read now
Antonio Clavenna & Maurizio Bonati. (2017) Pediatric pharmacoepidemiology - safety and effectiveness of medicines for ADHD. Expert Opinion on Drug Safety 16:12, pages 1335-1345.
Read now
Annabeth P. Groenman, Lizanne J.S. Schweren, Andrea Dietrich & Pieter J. Hoekstra. (2017) An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder. Expert Opinion on Drug Safety 16:4, pages 455-464.
Read now

Articles from other publishers (22)

Maria Niarchou, Julia M. Sealock, Peter Straub, Sandra Sanchez‐Roige, James S. Sutcliffe & Lea K. Davis. (2022) A phenome‐wide association study of polygenic scores for attention deficit hyperactivity disorder across two genetic ancestries in electronic health record data. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 189:6, pages 185-195.
Crossref
Ying Guo, Jinping Wang, Shuyan Yan & Shujie Sui. (2022) Clinical Efficacy Evaluation of Psychological Nursing Intervention Combined with Drugs Treatment of Children with ADHD under Artificial Intelligence. Journal of Healthcare Engineering 2022, pages 1-10.
Crossref
Di Fu, Dan-Dan Wu, Hong-Li Guo, Ya-Hui Hu, Ying Xia, Xing Ji, Wei-Rong Fang, Yun-Man Li, Jing Xu, Feng Chen & Qian-Qi Liu. (2022) The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review. Frontiers in Psychiatry 12.
Crossref
J. J. Sandra KooijJ. J. Sandra Kooij. 2022. Adult ADHD. Adult ADHD 87 149 .
虹 王. (2020) Application of Family Therapy in the Treatment of Children and Adolescents Mental Diseases. Advances in Psychology 10:12, pages 2044-2051.
Crossref
Tayfun KaraAjda Mutlu MıhçıoğluSemra Yılmazİsmail Akaltun. (2018) Effects of Long-Term Use of Prescription Methylphenidate on Myocardial Performance in Children with Attention-Deficit/Hyperactivity Disorder: A Tissue Doppler Imaging Study. Journal of Child and Adolescent Psychopharmacology 28:10, pages 676-681.
Crossref
Johanne Telnes Instanes, Kari Klungsøyr, Anne Halmøy, Ole Bernt Fasmer & Jan Haavik. (2016) Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review. Journal of Attention Disorders 22:3, pages 203-228.
Crossref
Eugenia Chan, Katherine A. Trier & Peter J. Chung. 2018. Developmental and Behavioral Pediatrics. Developmental and Behavioral Pediatrics.
Carlin J. Miller. 2018. Encyclopedia of Adolescence. Encyclopedia of Adolescence 319 336 .
Sheena Sharma, Kevin E. Meyers & Smitha R. Vidi. 2018. Pediatric Hypertension. Pediatric Hypertension 431 449 .
Mary Margaret Gleason. (2017) Pediatric Psychopharmacology: a Primer for the Treatment of Common Mental Health Conditions. Current Treatment Options in Pediatrics 3:2, pages 57-68.
Crossref
Jan Sieluk, Brittany Palasik, Susan dosReis & Peter Doshi. (2017) ADHD medications and cardiovascular adverse events in children and adolescents: cross-national comparison of risk communication in drug labeling. Pharmacoepidemiology and Drug Safety 26:3, pages 274-284.
Crossref
Philip Skoretz & Chin Tang. (2016) Stimulants for impulsive violence in schizophrenia spectrum disordered women: a case series and brief review. CNS Spectrums 21:6, pages 445-449.
Crossref
Øystein Karlstad, Helga Zoëga, Kari Furu, Shahram Bahmanyar, Jaana E Martikainen, Helle Kieler & Anton Pottegård. (2016) Use of drugs for ADHD among adults—a multinational study among 15.8 million adults in the Nordic countries. European Journal of Clinical Pharmacology 72:12, pages 1507-1514.
Crossref
Alexander K.C. Leung & Kam Lun Hon. (2016) Attention-Deficit/Hyperactivity Disorder. Advances in Pediatrics 63:1, pages 255-280.
Crossref
Lisa L. Giles & D. Richard Martini. (2016) Challenges and Promises of Pediatric Psychopharmacology. Academic Pediatrics 16:6, pages 508-518.
Crossref
Antonio Clavenna, Laura Reale, Daniele Piovani & Maurizio Bonarti. (2016) Psicofarmaci in età adolescenziale. RIVISTA SPERIMENTALE DI FRENIATRIA:2, pages 79-101.
Crossref
Victoria A. Reed, Jan K. Buitelaar, Ernie Anand, Kathleen Ann Day, Tamás Treuer, Himanshu P. Upadhyaya, David R. Coghill, Ludmila A. Kryzhanovskaya & Nicola C. Savill. (2016) The Safety of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Research. CNS Drugs 30:7, pages 603-628.
Crossref
Susanne Walitza, Manfred Gerlach, Marcel Romanos & Tobias Renner. 2016. Neuro-/Psychopharmaka im Kindes- und Jugendalter. Neuro-/Psychopharmaka im Kindes- und Jugendalter 289 331 .
Carlin J. Miller. 2016. Encyclopedia of Adolescence. Encyclopedia of Adolescence 1 18 .
Sheena Sharma, Kevin E. Meyers & Smitha R. Vidi. 2016. Pediatric Hypertension. Pediatric Hypertension 1 20 .
Antonio Clavenna & Maurizio Bonati. 2016. Pharmacovigilance in Psychiatry. Pharmacovigilance in Psychiatry 233 253 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.